15 January 2025
VIVEbiotech named finalist for CMO/CDMO of the Year at Advanced Therapies Awards
Excitement builds as our team heads to Dallas for Advanced Therapies Week conference.
GMP CDMO focused on different stages of the process.
We work exclusively in lentivirus, offering comprehensive services.
Technical adaptation and timely slot availability for each project.
Compliance with EMA and FDA regulatory requirements.
in the US, Europe, Asia and Australia
in reactor since 2020
since 2018
exclusively to lentivirus production
combining young talent and experience
We are a Contract Development and Manufacturing Organization (CDMO) with over 40 biotech companies worldwide that have placed their trust in us.
Read moreVIVEbiotech is one of the only companies in the world specialized exclusively in lentiviral vectors. One of the things that sets us apart is our expertise not only in production but also virology, backed by a team of professionals with more than 30 years of experience.
Read more15 January 2025
Excitement builds as our team heads to Dallas for Advanced Therapies Week conference.
16 December 2024
VIVEbiotech will be an exhibitor at Phacilitate's Advanced Therapies Week to be held in Dallas...